Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
about
Novel strategies to target the ubiquitin proteasome system in multiple myelomaIAP antagonists induce anti-tumor immunity in multiple myeloma.Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3.A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple MyelomaSmac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma.Signaling Pathways and Emerging Therapies in Multiple Myeloma.The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis.Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer.Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001.Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma.Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma CellsInhibitors of apoptosis: clinical implications in cancer.Kaempferol mitigates Endoplasmic Reticulum Stress Induced Cell Death by targeting caspase 3/7.Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
P2860
Q26773246-87C15C72-6D59-469F-9CCA-64F7FF4B0070Q33914862-4C943296-24A8-41A4-B232-2C88BAB31A84Q35833040-B9315552-3535-47F0-BBC8-417FA757A8FBQ36356398-F2E8D035-9CFD-4485-969C-9FB48ED1D252Q36846723-0374DF19-3965-4F08-AFD7-AE1F74A0C371Q37210703-16FCDD79-68DC-4BB6-8B5E-AF091669230EQ37636618-F90AF3CA-9053-45F7-81B4-82EE0199E8C3Q38753307-1B8A7F14-1611-48A9-B7D7-A94AB41C90F1Q38755349-BBDFEA29-E3A2-40C3-BBC0-045576B2D7EEQ38845220-877319B8-3FB3-462F-8D23-8078BACA8656Q38868257-DFF6F869-17D5-43B9-B2E6-4D384CEFFD5DQ38950582-57961106-9B37-4F85-B2E5-3DCBBB945F98Q39286167-E8F044A4-7A4B-4F94-8997-8C7BCB7D9761Q39633869-B932666B-1B2D-456C-B811-74ADDAB43C68Q47607136-CB3CE7BF-32EA-48FF-9B1A-7D45856C8FB9Q49389276-DF49F280-85AF-4DEC-9E7A-5BE6174A8AD2Q50204389-A286AF09-FEC8-4F39-8C8D-B3D8CA20C6FAQ57818334-9A0DBC52-388A-4A09-8D0D-EFCA2A3B6DDF
P2860
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@ast
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@en
type
label
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@ast
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@en
prefLabel
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@ast
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@en
P2093
P2860
P356
P1433
P1476
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2014.2
P577
2014-01-09T00:00:00Z
P5875
P6179
1021271239